secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inari Medical, Inc. (—)
CIK:        0001531048
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001193125-25-029190
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 5.01, 5.03, 3.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker completes $4.94B acquisition of Inari Medical; shares delisted
----------------------------------------------------------------------

- Tender offer accepted 48.5M shares (81.69%) at $80.00/share; merger closed under DGCL 251(h).
- Total aggregate consideration ~$4.94B cash; funded from Stryker cash and debt.
- Inari Board resigned; William E. Berry Jr. and J. Andrew Pierce appointed directors; officers remain.
- Shares to be delisted from Nasdaq; Form 15 to be filed to suspend SEC reporting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/d932380d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-029190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer